Leandros Lazaros

Leandros Lazaros

Auto-generated profile, based on publicly available information

Leandros Lazaros

Genetics and IVF Unit, Department of Obstetrics and Gynecology, Medical School, Ioannina University, Ioannina, Greece

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LLL. Lazaros
L. Lazaros
SMSofia I. Markoula
Sofia I. Markoula
NXN. Xita
N. Xita
Sotirios GiannopoulosSotirios Giannopoulos
Sotirios Giannopoulos
PGP. Gogou
P. Gogou
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
The vascular protective effects of estrogens are mediated by their binding to the two known estrogen receptors. In this study, we examine the association of stroke with two common polymorphisms of the ESR1 gene in patients with metabolic syndrome. DNA from 130 patients hospitalized for ischemic stroke and 240 healthy controls were genotyped for ESR1 PvuII and XbaI polymorphisms. Results - Comparing female and male patients, it was found that CCGG diplotype is more frequent in male patients (P = 0.03). In addition, the AA genotype is associated with the onset of stroke at a younger age in the male patient group (P < 0.05). These findings suggest that PvuII and XbaI polymorphisms may affect the age at onset of the first stroke and the probability of developing cerebrovascular disease.

4 March 2013 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
PDF file
LLLeandros Lazaros
Leandros Lazaros
GVGeorge Vartholomatos
George Vartholomatos
CPChristina Pamporaki
Christina Pamporaki
IKIoannis Kosmas
Ioannis Kosmas
ATAtsushi Takenaka
Atsushi Takenaka
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou

1 January 2011 in Fertility and Sterility
Verified
Journal Article
Closed access
LLLeandros Lazaros
Leandros Lazaros
AKApostolos Kaponis
Apostolos Kaponis
GVGeorge Vartholomatos
George Vartholomatos
EHElissavet Hatzi
Elissavet Hatzi
SBStefania Botsari
Stefania Botsari
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou

10 June 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MPMichail Pargianas
Michail Pargianas
SSStyliani Salta
Styliani Salta
KAKaterina Apostolopoulou
Katerina Apostolopoulou
LLLeandros Lazaros
Leandros Lazaros
Maria KyrgiouMaria Kyrgiou
Maria Kyrgiou
IKIoannis Kosmas
Ioannis Kosmas
Premature ovarian failure (POF), which may be undetectable for a long time, is associated with impaired fertility. The mechanisms involved in the pathogenesis of POF as well as the concomitant treatments are still unclear. Although many data exist, mainly produced by the study of transgenic animals under various experimental conditions, they remain fragmented. A systematic review of the pathways involved in premature ovarian failure was conducted. Data extraction was performed from experimental studies until 2019. The molecular processes and their correlation with the follicular developmental stage have been described. Furthermore, the effects in other cells, such as oocytes, granulosa and theca cells have been reported. An overall estimation was conducted.

1 January 2015
Verified
Book Chapter
Closed access
PDF file
VGVasiliki Galani
Vasiliki Galani
SMSofia I. Markoula
Sofia I. Markoula
LLLeandros Lazaros
Leandros Lazaros
PLParis Ladias
Paris Ladias
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou